This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
based OSF HealthCare's Childrens Hospital of Illinois became the first in the world to implant an extravascular implantable, cardioverter-defibrillator in a pediatric patient who had suffered sudden cardiac arrest. A team at Peoria, Ill.-based
Among pediatric patients undergoing orthotopic heart transplantation (OHT), 1-12% are reported to need a permanent pacemaker (PPM).1 1 There are limited studies on the outcomes of PPM placement, and the role of implantable cardioverter-defibrillator (ICD) in pediatric OHT remains unclear.
Sarah Reid on pediatric appendicitis risk calculator, Sheldon Cheskes & Mark Ramzy on double defibrillation for refractory ventricular fibrillation, Hans Rosenberg & Krishan Yadav on cellulitis clinical pearls, Anand Swaminathan on serratus anterior block, Brit Long on recognition of toxic shock syndrome, Justin Morgenstern on tranexamic acid (..)
The subcutaneous implantable cardioverter-defibrillator (SICD) was developed with an aim to avoid lead-related complications associated with transvenous ICD (TV-ICD) systems. Patient selection and implant techniques have evolved greatly since that time.
If they have a pacemaker or not, and a wallet card A wallet card identifying the manufacturer of a pacemaker or defibrillator is very important, especially in case of emergency. For the most part, pediatric cardiologists already do an excellent job with this type of counseling.
The guideline, according to a written statement shared here, reiterates the importance of collaborative decision-making with patients who have HCM and provides updated recommendations for the most effective treatment pathways for adult and pediatric patients. Several recommendations in the new guideline extend to pediatric patients.
Praluent (alirocumab) (Approved: 03/11/2024) Extended to pediatric patients aged 8+ with heterozygous familial hypercholesterolemia (HeFH). Join us as we examine the landmark approvals that are revolutionizing patient outcomes.
Topics addressed by systematic reviews this year include resuscitation of cardiac arrest from drowning, extracorporeal cardiopulmonary resuscitation for adults and children, calcium during cardiac arrest, double sequential defibrillation, neuroprognostication after cardiac arrest for adults and children, maintaining normal temperature after preterm (..)
She was given CRT-D (Cardiac Resynchronization Therapy-Defibrillator). The biopsy was consistent with cardiac sarcoidosis. Medical treatment with oral steroids and methotrexate was started. The ECG below was recorded after her device was implanted. The ECG shows atrial sensing and biventricular paced rhythm.
Pediatric and elderly patients were more predisposed to developing an arrhythmic event in the setting of fever [7]. Recently the rate of true arrhythmic events related to fevers in the classic Brugada Type 1 syndrome was explored by Michowitz et al.
The primary composite outcome included sustained ventricular arrhythmia, appropriate implantable cardioverter defibrillator (ICD) therapy, aborted cardiac arrest, or sudden cardiac death.RESULTS:A total of 100 primary prevention children were included (7.15.6 males), with a mean follow-up of 8.65.5
Implantable Cardioverter-Defibrillator ), with long-term potential for device-related complications from the ICD, including inappropriate shocks? VF w as induced at EP study in 9 of 19 patients (47%). An SCN5A mutation was found in 14 of 28 patients (50%).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content